I last looked at Orthocell (ASX: OCC) on 26 April, and here's what I said: OCC - Got FDA approval and have now appointed USA distributors. There are more distributors to be appointed by June 30. I expect this share price to rise very nicely from now on and to bring a good medium-term return. Realistically, give the company 6 months to realise sales in the USA. Buy now, sell then. I really like this West Australian company, they are producing great products. Here we are, about 4 weeks out from that 6-month date and what has happened? The price got as low as $1.10 (from $1.29 in April) and then, just this month, news started to really roll in and it was good news. As I write this the share price has shot up to $1.46. Once again, I suspect these guys will suffer a little from Donald Trump's announcement and the market's misunderstanding of what that announcement actually means and who it affects. But I would expect these guys to settle on a new (higher) level shortly. And then...